Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs At Risk
- Conditions
- Breast CancerEsophageal CancerLung Cancer
- Interventions
- Device: contouring of thoracic organs at risk
- Registration Number
- NCT05787522
- Brief Summary
The goal of this clinical trial is to evaluate performance and clinical applicability of AI-assisted radiotherapy contouring software for thoracic organs at risk. The main question it aims to answer is:
• Does AI-assisted contouring (AI contouring with manual modification) offer greater accuracy and time efficiency compared to manual contouring? After screening, the qualified participants' thoracic CT images will be anonymized and segmented using three methods: manual, AI (AI-only), and AI-assisted contouring. The researchers will compare the results generated by the three different contouring methods with the ground truth established by expert consensus, in order to evaluate both accuracy and time-related parameters
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 500
- ≥18 years old, no gender limit.
- Patients diagnosed with breast cancer, lung cancer, or esophageal cancer, who are scheduled for chest CT scanning followed by thoracic radiotherapy.
- CT slice thickness ≤5mm.
- Patients understand the goal of the trial, are willing to attend the trial and sign the informed consent.
- Congenital malformations or abnormal anatomical structures resulting from non-tumor factors in the scan area.
- Artifact, prosthesis or implantation causing images undistinguishable.
- CT images not conforming to DICOM standards.
- Investigators consider not suitable.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description control group contouring of thoracic organs at risk independent investigator contouring of thoracic organs at risk experimental group contouring of thoracic organs at risk software-assisted contouring of thoracic organs at risk golden standard group contouring of thoracic organs at risk contouring of thoracic organs at risk by a team of experts, in which contours by two experts separately will be arbitrated by the third expert as the golden standard
- Primary Outcome Measures
Name Time Method DICE similarity coefficient, DSC Within 6 months after enrollment DSC= 2×(A∩B)/(A+B), A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring.
Contouring time (min) Within 6 months after enrollment Manual contouring time is recorded from the time the CT is loaded on the contouring platform to the completion of contouring. AI-assisted contouring time is defined as the sum of the auto-segmentation model runtime, the transfer to the contouring platform, and the subsequent manual modification.
- Secondary Outcome Measures
Name Time Method Volumetric revision index, VRI Within 6 months after enrollment VRI = \[(A- A∩B) + (B- A∩B)\] /A, A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring
Rate of time efficiency improvement Within 6 months after enrollment Rate of efficiency time improvement= (manual contouring duration - AI-assisted contouring duration)/ manual contouring duration\*100%
Rate of volume difference, DV Within 6 months after enrollment DV = (A-B) /B, A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring
Recall, Rec Within 6 months after enrollment Rec = \| A∩B\| / A, A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring
Precision, Pre Within 6 months after enrollment Pre= \|A∩B\| / B, A refers to the volume of ground-truth, B refers to the volume of manual, AI, or AI-assisted contouring
Investigators satisfaction score for AI contouring Within 6 months after enrollment Evaluated on a 1-5 Likert scale: 1 - very dissatisfied, 2 - somewhat dissatisfied, 3 - neutral, 4 - somewhat satisfied, 5 - very satisfied. Assessment conducted after AI-assisted contouring by the investigators.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy
🇨🇳Tianjin, Tianjin, China